Interpace Diagnostics Group, In (NASDAQ:IDXG) is at $1.27 seeing a daily low of $1.26 and high of $1.37. This range of trading makes the stock one of the most volatile of the day.
The stock is among the market’s biggest losers today. It is currently trading at $1.27 which is well below $1.52, the 50 day moving average and significantly lower than the 200 day moving average of $1.56. The 50 day moving average went down by -16.49% and the 200 day average was down $-0.29.
Investors are more bullish recently if you consider the downtick in short interest. The stock saw a fall in short interest between September 15, 2017 and September 29, 2017 of -6.12%. Short shares decreased from 3,671,693 to 3,446,935 over that timeframe. The days to cover increased to 3.0 and the short interest percentage is 0.36% as of September 29.
Recent Analyst Ratings
On August 15, 2017 Maxim Group starting coverage on the stock giving it an initial rating of “Buy”.
Interpace Diagnostics Group, Inc., formerly PDI, Inc., launched on February 10, 1998, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment, which focuses on developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management..